Infinity minus one: shares plummet as spiky saridegib fails in pancreatic cancer
30 January 2012
Nancy Faigen
Please Login to read the full article.
30 January 2012
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- With expert's help, Talon wins ODAC support for Marqibo
- Mundipharma commits $50M to Infinity for PI3K inhibitors during 2013
- Celldex's CDX-011 EMERGEs as advantageous targeted option in advanced breast cancer
- Peregrine holds out for survival data as tepid Phase II PFS in NSCLC vexes market
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
